Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Institut Claudius Regaud |
---|---|
Information provided by: | Institut Claudius Regaud |
ClinicalTrials.gov Identifier: | NCT00210041 |
The purpose of this study is to determine whether association Gemcitabine-Cisplatin is effective in the treatment of penis epidermoid carcinoma loco-regionally advanced or metastatic.
Condition | Intervention | Phase |
---|---|---|
Genital Neoplasms, Male |
Drug: Gemcitabine Drug: Cisplatin |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | Phase 2 Study for Treatment of Penis Epidermoid Carcinoma Loco-Regionally Advanced or Metastatic by Association Gemcitabine-Cisplatin |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Christine CHEVREAU, Doctor | +33 5.61.42.41.18 | Chevreau.Christine@claudiusregaud.fr |
France | |
Institut Claudius Regaud | Recruiting |
Toulouse, France | |
Contact: Christine Chevreau, Doctor +33 5.59.42.41.18 Chevreau.Christine@claudiusregaud.fr | |
Sub-Investigator: Florence Dalenc, Doctor | |
Sub-Investigator: Jean Pierre Delord, Doctor | |
Sub-Investigator: Loic Mourey, Doctor | |
Centre Paul Papin | Recruiting |
Angers, France | |
Contact: R. Delva, Dr | |
Institut Bergonie | Recruiting |
Bordeaux, France | |
Contact: N. Tchen, Dr | |
Centre François Baclesse | Recruiting |
Caen, France | |
Contact: E. Sevin, Dr | |
Institut Curie | Recruiting |
Paris, France | |
Contact: P. Beuzeboc, Dr | |
Centre Médico-Chirurgical Foch | Recruiting |
Suresnes, France | |
Contact: L. Mignot, Dr | |
Centre Léon Bérard | Recruiting |
Lyon, France | |
Contact: A. Flechon, Dr | |
Institut Paoli Calmette | Recruiting |
Marseille, France | |
Contact: G. Gravis, Dr | |
Institut Val d'aurelle | Recruiting |
Montpellier, France | |
Contact: S. Culine, Dr | |
Centre Eugène Marquis | Recruiting |
Rennes, France | |
Contact: Kerbrat, Dr | |
CHU Grenoble | Recruiting |
Grenoble, France | |
Contact: N. Tchen, Dr |
Principal Investigator: | Christine Chevreau, Doctor | Institut Claudius Regaud |
Study ID Numbers: | 03 GENH 06, 02 GENM 02 |
Study First Received: | September 2, 2005 |
Last Updated: | November 10, 2006 |
ClinicalTrials.gov Identifier: | NCT00210041 |
Health Authority: | France: Afssaps - French Health Products Safety Agency |
Genital Neoplasms, Male |
Epidermoid carcinoma Cisplatin Genital Neoplasms, Male Squamous cell carcinoma Carcinoma, squamous cell Urogenital Neoplasms |
Neoplasms, Squamous Cell Gemcitabine Genital Diseases, Male Carcinoma, Squamous Cell Neoplasms, Glandular and Epithelial Carcinoma |
Antimetabolites Anti-Infective Agents Neoplasms by Histologic Type Antimetabolites, Antineoplastic Immunologic Factors Molecular Mechanisms of Pharmacological Action Antineoplastic Agents Physiological Effects of Drugs |
Enzyme Inhibitors Immunosuppressive Agents Antiviral Agents Pharmacologic Actions Neoplasms Neoplasms by Site Radiation-Sensitizing Agents Therapeutic Uses |